Approval · Notice of Compliance 5331 · 1994
IOPIDINE: Notice of Compliance 5331
Issued March 1, 1994
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5331
- Date
- March 1, 1994
- Company
- Alcon Canada Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New strength, new indication
- Therapeutic class
- Glaucoma therapy
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| IOPIDINE | 02076306 | Marketed |
Medicinal ingredients
- APRACLONIDINE HCL 0.5 PER